Category: Merrill Goozner
New cancer drugs offer hope — but at an often staggering cost
Julie Grabow, an oncologist at the Fred Hutchinson Cancer Center in Seattle, recently prescribed an exciting new therapy for a 60-year-old woman with metastatic breast cancer — Afinitor made by Novartis. There was a catch, though. Novartis is charging $10,000 per month for the drug
Health care reform: Prove it works and we’ll pay
With reference pricing, to charge Medicare extra companies get three years to show that a new, costly treatment is better than the old one.
Breast Cancer: How politics is driving up costs
FDA shouldn’t cave to pressure and allow Genentech to keep advanced metastatic breast cancer on the Avastin label, argues Merrill Goozner.
Bad Medicine: The Real Cost of a Dangerous Drug
Clinical trials that compare effectiveness–and safety–of new drugs with old drugs would not only save lives, but money as well, says Merrill Goozner
LocalHealthGuide is a health news and information web service for Seattle and the Puget Sound Region. We are independent and unaffiliated with any hospital, medical association or insurer. If you have questions or if your group has an upcoming event that you would like us to cover, please let us know by going to our "
Recent Comments